Company / AR per Share
TENAX THERAPEUTICS, INC. AR per Share History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.00
FY2016
5-year range
$0.00 / $0.02
FY2012-FY2016
Trend
+97.8%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share returned to growth in FY2016 after 2 years of decline, reaching $0.00.
Based on SEC 10-K filings.
0.00 in FY2016 with a 3-year CAGR of -79.6%.
Declined from $0.02 to $0.00 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- -79.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, ar per share increased 97.8% year-over-year.
- Peak ar per share was recorded in FY2013.
- Lowest ar per share in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2016 | $0.00 | +97.8% |
| FY2015 | $0.00 | -93.1% |
| FY2014 | $0.02 | -93.8% |
| FY2013 | $0.30 | +52803.5% |
| FY2012 | $0.00 | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026